Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M84,719Revenue $M20,179Net Margin (%)11.5Altman Z-Score4.2
Enterprise Value $M89,870EPS $2.2Operating Margin %5.3Piotroski F-Score8
P/E(ttm)35.4Beneish M-Score-2.6Pre-tax Margin (%)13.6Higher ROA y-yY
Price/Book5.710-y EBITDA Growth Rate %11.9Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %-10.5Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow48.2y-y EBITDA Growth Rate %6.0ROA % (ttm)6.5Higher Current Ratio y-yY
Dividend Yield %2.6PEG--ROE % (ttm)15.6Less Shares Outstanding y-yY
Payout Ratio %92.0Shares Outstanding M1,104ROIC % (ttm)0.3Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYVanguard Health Care Fund 2016-03-31 Add0.21%$69.06 - $84.26
($75.82)
$ 76.751%Add 5.49%25,959,710
LLYKen Fisher 2016-03-31 Add0.04%$69.06 - $84.26
($75.82)
$ 76.751%Add 18.63%1,746,388
LLYVanguard Health Care Fund 2015-12-31 Add0.13%$76.98 - $87.52
($83.01)
$ 76.75-8%Add 3.16%24,609,530
LLYKen Fisher 2015-12-31 Add0.04%$76.98 - $87.52
($82.95)
$ 76.75-7%Add 18.78%1,472,117
LLYDavid Dreman 2015-12-31 Sold Out -0.01%$76.98 - $87.52
($83.01)
$ 76.75-8%Sold Out0
LLYMario Gabelli 2015-12-31 Reduce-0.01%$76.98 - $87.52
($83.01)
$ 76.75-8%Reduce -13.84%84,350
LLYDodge & Cox 2015-12-31 Reduce$76.98 - $87.52
($83.01)
$ 76.75-8%Reduce -0.13%31,592
LLYHOTCHKIS & WILEY 2015-09-30 Reduce-1.13%$78.26 - $89.98
($84.37)
$ 76.75-9%Reduce -99.30%26,900
LLYVanguard Health Care Fund 2015-09-30 Reduce-0.26%$78.26 - $89.98
($84.37)
$ 76.75-9%Reduce -5.99%23,854,960
LLYKen Fisher 2015-09-30 Add0.04%$78.26 - $89.98
($84.37)
$ 76.75-9%Add 20.44%1,239,408
LLYDodge & Cox 2015-09-30 Reduce$78.26 - $89.98
($84.37)
$ 76.75-9%Reduce -3.06%31,634
LLYCharles Brandes 2015-06-30 Sold Out -0.11%$70.89 - $86.59
($76.14)
$ 76.751%Sold Out0
LLYVanguard Health Care Fund 2015-06-30 Add0.08%$70.89 - $86.59
($76.14)
$ 76.751%Add 1.94%25,375,160
LLYKen Fisher 2015-06-30 Add0.04%$70.89 - $86.59
($76.14)
$ 76.751%Add 29.29%1,029,030
LLYHOTCHKIS & WILEY 2015-06-30 Reduce-0.03%$70.89 - $86.59
($76.14)
$ 76.751%Reduce -2.52%3,868,109
LLYDodge & Cox 2015-06-30 Reduce$70.89 - $86.59
($76.14)
$ 76.751%Reduce -9.94%32,634
LLYMario Gabelli 2015-06-30 Reduce$70.89 - $86.59
($76.14)
$ 76.751%Reduce -12.43%97,900
LLYVanguard Health Care Fund 2015-03-31 Add0.45%$68.41 - $76.36
($71.19)
$ 76.758%Add 13.24%24,892,160
LLYCharles Brandes 2015-03-31 Reduce-0.06%$68.41 - $76.36
($71.19)
$ 76.758%Reduce -36.80%107,025
LLYKen Fisher 2015-03-31 Add0.03%$68.41 - $76.36
($71.19)
$ 76.758%Add 37.46%795,909
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2016-04-29Sell180,000$75.441.74view
Zulueta Alfonso GSVP& Pres., Emerging Markets 2016-04-27Sell12,000$76.270.63view
LILLY ENDOWMENT INC10% Owner 2016-04-08Sell200,000$74.293.31view
Fry Stephen FSVP, HR & Diversity 2016-02-05Sell15,230$78.87-2.69view
Ricks David ASVP and Pres, Lilly Bio-Meds 2016-02-03Sell5,733$77.66-1.17view
Rice Derica WEVP-Global Services and CFO 2016-02-03Sell10,483$77.78-1.32view
Fry Stephen FSVP, HR & Diversity 2016-02-03Sell3,137$77.94-1.53view
TAI JACKSON PDirector 2016-02-01Buy3,170$78.62-2.38view
Zulueta Alfonso GSVP& Pres., Emerging Markets 2016-01-29Sell5,000$78.75-2.54view
LILLY ENDOWMENT INC10% Owner 2015-12-21Sell205,000$86-10.76view

Quarterly/Annual Reports about LLY:

News about LLY:

Articles On GuruFocus.com
Manning & Napier Sells Chunks of Stakes in GE, Eli Lilly, Merck Mar 29 2016 
Sanofi's New Products Will Fuel Sales Mar 13 2016 
Steven Cohen Makes Eli Lilly, Kraft Heinz, American Axle and Airgas 3rd Quarter New Buys Jan 07 2016 
Mairs and Power Sells Baxalta, Walt Disney, Target Dec 16 2015 
HOTCHKIS & WILEY Buys More Than 7 Million Shares in Oil and Gas Company Dec 02 2015 
John Hussman Buys, Sells Most Valuable Stakes in Second Quarter Aug 04 2015 
Weekly 52-Week Highs Highlight: LLY, PLL, SBUX, VLO Jul 07 2015 
Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks Jun 11 2015 
Abbvie Inc. Dividend Stock Analysis May 26 2015 

More From Other Websites
Lilly Releases First-Ever Integrated Report May 02 2016
Lilly Releases First-Ever Integrated Report May 02 2016
Lilly's Taltz® (ixekizumab) Now Available in the U.S. for the Treatment of Moderate-to-Severe... May 02 2016
Lilly Declares Second-Quarter 2016 Dividend May 02 2016
Lilly Declares Second-Quarter 2016 Dividend May 02 2016
2:02 pm Eli Lilly announces that Taltz is now available in U.S. May 02 2016
Lilly's Taltz® (ixekizumab) Now Available in the U.S. for the Treatment of Moderate-to-Severe... May 02 2016
How Did Eli Lilly’s Neuroscience Franchise Perform in 1Q16? May 02 2016
Must-See Charts: How Healthy Are Bristol-Myers, Eli Lilly, Pfizer, Merck? May 02 2016
How Did Eli Lilly’s Endocrinology Franchise Perform in 1Q16? May 02 2016
How Did Eli Lilly’s 1Q16 Business Segment Perform? Apr 29 2016
LILLY ELI & CO Files SEC form 10-Q, Quarterly Report Apr 29 2016
What Drove Eli Lilly’s 1Q16 Earnings Growth? Apr 28 2016
How Did Eli Lilly Perform in 1Q16? Apr 28 2016
Lilly to Participate in Bank of America Merrill Lynch 2016 Health Care Conference Apr 28 2016
Lilly to Participate in Bank of America Merrill Lynch 2016 Health Care Conference Apr 28 2016
ETF’s with exposure to Eli Lilly & Co. : April 28, 2016 Apr 28 2016
Adocia and Lilly announce positive topline results from a Phase 1b study of repeated administration... Apr 27 2016
Company News for April 27, 2016 Apr 27 2016
Eli Lilly & Co. :LLY-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)